The Six Food Elimination in Postprandial Distress Syndrome
NCT05651386 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2024-07-03
Summary
The six food elimination diet, as known in eosinophilic esophagitis, will be performed in 15 patients with functional dyspepsia (subtype postprandial distress syndrome). Screening will exclude patients with allergies by performing immunocaps on blood. Before and after the 8 weeks of diet, an gastroduodenoscopy with biopsies will be performed to evaluate duodenal eosinophilia, mast cells and permeability. To evaluate gastric sensorimotor function, a gastric emptying breath test and a barostat test will be performed before and after the diet.
Symptoms will be monitored with a daily diary (LPDS diary) and food intake will be evaluated during 2 weeks.
If there is an improvement of symptoms during the diet, a reintroduction period will start. This period will last 6 weeks. Every 2 weeks, two food groups will be reintroduced. When there is a clear worsening in symptoms, a new endoscopy with biopsies will be performed.
Conditions
- Functional Dyspepsia
Interventions
- OTHER
-
Diet
No blinded, no controlled intervention.
Sponsors & Collaborators
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Jan Tack, MD, PhD · KU Leuven
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-02-19
- Primary Completion
- 2025-01-31
- Completion
- 2025-01-31
Countries
- Belgium
Study Locations
More Related Trials
-
PEA in Functional Dyspepsia
NCT05877781 ·Status: RECRUITING ·Phase: NA
-
Postprandial Distress Itopride Cohort Trial
NCT07165301 ·Status: NOT_YET_RECRUITING
-
Therapeutic Effect of Ursodeoxycholic Acid in Functional Dyspepsia
NCT03004118 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Responses to a Comfort Meal in Functional Dyspepsia
NCT04722419 ·Status: COMPLETED ·Phase: NA
-
A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia
NCT05655819 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Primary Care dySpEpsia rikkuNshiTo
NCT06482671 ·Status: RECRUITING ·Phase: PHASE3
-
To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia
NCT00761358 ·Status: COMPLETED ·Phase: PHASE3
-
An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia
NCT00358410 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Galeo® in Patients With Postprandial Distress Syndrome Subtype in Functional Dyspepsia
NCT05199441 ·Status: COMPLETED ·Phase: PHASE4
-
Advancing Nutritional Science for Children With Functional Dyspepsia
NCT04053049 ·Status: COMPLETED ·Phase: NA
-
Effectiveness and Safety in Administrating CNU® Capsule to Refractory Functional Dyspepsia Patients
NCT03844100 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Budesonide as a Treatment for Functional Dyspepsia
NCT06841406 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Evaluate the Effects of ABX-1431 on Patients With Functional Dyspepsia
NCT02875678 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of Food Hypersensitivity in Children/Adolescents With Functional Dyspepsia
NCT00328679 ·Status: COMPLETED ·Phase: PHASE1
-
Trial to Reduce Inappropriate Oesophagogastroduodenoscopies for Dyspepsia
NCT03205319 ·Status: COMPLETED ·Phase: NA
-
Clinical Course of Functional Dyspepsia and Factors Predicting Outcome in Patients Receiving Medication-based Treatment
NCT05513040 ·Status: RECRUITING
-
Open-Label Placebo for Functional Dyspepsia
NCT03745781 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
The Efficacy of Removal of Animal Milk From the Diet in Functional Dyspepsia: A Cross-sectional Study
NCT05750641 ·Status: COMPLETED
-
Mast Cells in Acid-induced Intestinal Permeability
NCT02664051 ·Status: TERMINATED ·Phase: PHASE4
-
Association Between Luminal Bile Salt Content and Duodenal Mucosal Integrity in Functional Dyspepsia
NCT03003234 ·Status: COMPLETED ·Phase: NA
-
Gastric Activity and Gastrointestinal Peptides in Patients With Functional Dyspepsia
NCT02113527 ·Status: COMPLETED
-
G-POEM vs PEG-J in Gastroparesis Patients
NCT06372132 ·Status: RECRUITING ·Phase: NA
-
Traditional Chinese Medicine Xiang-sha-liu-jun Granules in Patients With Postprandial Distress Syndrome(PDS)
NCT02762136 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Tradipitant for Functional Dyspepsia
NCT05653310 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
The Effect of Rikkunshito on Gastric Accommodation and Nutrient Volume Tolerance in Functional Dyspepsia
NCT03856294 ·Status: COMPLETED ·Phase: PHASE2